nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALPL—prostate cancer	0.656	1	CbGaD
Fospropofol—ALB—Abiraterone—prostate cancer	0.0567	0.401	CbGbCtD
Fospropofol—ALB—Estrone—prostate cancer	0.041	0.29	CbGbCtD
Fospropofol—ALB—Estradiol—prostate cancer	0.0236	0.166	CbGbCtD
Fospropofol—ALB—Prednisone—prostate cancer	0.0203	0.143	CbGbCtD
Fospropofol—Propofol—CYP2C18—prostate cancer	0.0019	0.244	CrCbGaD
Fospropofol—Tingling sensation—Conjugated Estrogens—prostate cancer	0.00161	0.016	CcSEcCtD
Fospropofol—Propofol—CYP1B1—prostate cancer	0.00157	0.202	CrCbGaD
Fospropofol—Hepatic failure—Bicalutamide—prostate cancer	0.00152	0.015	CcSEcCtD
Fospropofol—Angiopathy—Abiraterone—prostate cancer	0.0013	0.0129	CcSEcCtD
Fospropofol—Mediastinal disorder—Abiraterone—prostate cancer	0.00129	0.0128	CcSEcCtD
Fospropofol—Propofol—CYP2A6—prostate cancer	0.00121	0.156	CrCbGaD
Fospropofol—Cough—Abiraterone—prostate cancer	0.00108	0.0108	CcSEcCtD
Fospropofol—Angiopathy—Degarelix—prostate cancer	0.00106	0.0105	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Abiraterone—prostate cancer	0.00105	0.0104	CcSEcCtD
Fospropofol—Mediastinal disorder—Degarelix—prostate cancer	0.00105	0.0104	CcSEcCtD
Fospropofol—Tingling sensation—Etoposide—prostate cancer	0.000997	0.00989	CcSEcCtD
Fospropofol—Angiopathy—Cabazitaxel—prostate cancer	0.000996	0.00988	CcSEcCtD
Fospropofol—Cough—Nilutamide—prostate cancer	0.000991	0.00983	CcSEcCtD
Fospropofol—Mediastinal disorder—Cabazitaxel—prostate cancer	0.00099	0.00982	CcSEcCtD
Fospropofol—Skin disorder—Abiraterone—prostate cancer	0.000986	0.00978	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Flutamide—prostate cancer	0.000956	0.00949	CcSEcCtD
Fospropofol—Apnoea—Etoposide—prostate cancer	0.000946	0.00938	CcSEcCtD
Fospropofol—Skin disorder—Flutamide—prostate cancer	0.000896	0.00889	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Abiraterone—prostate cancer	0.000876	0.00869	CcSEcCtD
Fospropofol—Propofol—CYP2E1—prostate cancer	0.00086	0.11	CrCbGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Degarelix—prostate cancer	0.000858	0.00851	CcSEcCtD
Fospropofol—Angiopathy—Bicalutamide—prostate cancer	0.000855	0.00848	CcSEcCtD
Fospropofol—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.000854	0.00847	CcSEcCtD
Fospropofol—Pain—Estrone—prostate cancer	0.000853	0.00847	CcSEcCtD
Fospropofol—Propofol—CYP2C19—prostate cancer	0.000852	0.109	CrCbGaD
Fospropofol—Mediastinal disorder—Bicalutamide—prostate cancer	0.000849	0.00842	CcSEcCtD
Fospropofol—Propofol—CYP1A1—prostate cancer	0.000848	0.109	CrCbGaD
Fospropofol—Cough—Cabazitaxel—prostate cancer	0.000834	0.00828	CcSEcCtD
Fospropofol—Paraesthesia—Nilutamide—prostate cancer	0.000832	0.00826	CcSEcCtD
Fospropofol—Nervous system disorder—Degarelix—prostate cancer	0.000812	0.00806	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Cabazitaxel—prostate cancer	0.000808	0.00802	CcSEcCtD
Fospropofol—Skin disorder—Degarelix—prostate cancer	0.000804	0.00798	CcSEcCtD
Fospropofol—Tingling sensation—Capecitabine—prostate cancer	0.000802	0.00796	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Nilutamide—prostate cancer	0.0008	0.00794	CcSEcCtD
Fospropofol—Pain—Nilutamide—prostate cancer	0.000793	0.00786	CcSEcCtD
Fospropofol—Hypotension—Degarelix—prostate cancer	0.000774	0.00768	CcSEcCtD
Fospropofol—Nervous system disorder—Cabazitaxel—prostate cancer	0.000765	0.00759	CcSEcCtD
Fospropofol—Skin disorder—Cabazitaxel—prostate cancer	0.000758	0.00752	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.000752	0.00746	CcSEcCtD
Fospropofol—Pain—Estradiol valerate/Dienogest—prostate cancer	0.000745	0.00739	CcSEcCtD
Fospropofol—Pruritus—Estramustine—prostate cancer	0.000739	0.00733	CcSEcCtD
Fospropofol—Hypotension—Cabazitaxel—prostate cancer	0.000729	0.00723	CcSEcCtD
Fospropofol—Angiopathy—Ethinyl Estradiol—prostate cancer	0.000722	0.00717	CcSEcCtD
Fospropofol—Cough—Bicalutamide—prostate cancer	0.000715	0.0071	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Degarelix—prostate cancer	0.000715	0.00709	CcSEcCtD
Fospropofol—Pain—Degarelix—prostate cancer	0.000708	0.00703	CcSEcCtD
Fospropofol—Pruritus—Estrone—prostate cancer	0.000706	0.00701	CcSEcCtD
Fospropofol—Paraesthesia—Cabazitaxel—prostate cancer	0.0007	0.00695	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.000693	0.00688	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.000673	0.00668	CcSEcCtD
Fospropofol—Pain—Cabazitaxel—prostate cancer	0.000667	0.00662	CcSEcCtD
Fospropofol—Vomiting—Estramustine—prostate cancer	0.000664	0.00659	CcSEcCtD
Fospropofol—Nervous system disorder—Bicalutamide—prostate cancer	0.000656	0.00651	CcSEcCtD
Fospropofol—Pruritus—Nilutamide—prostate cancer	0.000656	0.00651	CcSEcCtD
Fospropofol—Headache—Estramustine—prostate cancer	0.000654	0.00649	CcSEcCtD
Fospropofol—Pruritus—Flutamide—prostate cancer	0.000653	0.00648	CcSEcCtD
Fospropofol—Skin disorder—Bicalutamide—prostate cancer	0.00065	0.00645	CcSEcCtD
Fospropofol—Vomiting—Abiraterone—prostate cancer	0.000645	0.0064	CcSEcCtD
Fospropofol—Vomiting—Estrone—prostate cancer	0.000635	0.0063	CcSEcCtD
Fospropofol—Headache—Estrone—prostate cancer	0.000625	0.0062	CcSEcCtD
Fospropofol—Nausea—Estramustine—prostate cancer	0.000621	0.00616	CcSEcCtD
Fospropofol—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000616	0.00611	CcSEcCtD
Fospropofol—Cough—Ethinyl Estradiol—prostate cancer	0.000605	0.006	CcSEcCtD
Fospropofol—Paraesthesia—Bicalutamide—prostate cancer	0.000601	0.00596	CcSEcCtD
Fospropofol—Angiopathy—Goserelin—prostate cancer	0.000594	0.0059	CcSEcCtD
Fospropofol—Nausea—Estrone—prostate cancer	0.000593	0.00588	CcSEcCtD
Fospropofol—Vomiting—Nilutamide—prostate cancer	0.000589	0.00585	CcSEcCtD
Fospropofol—Angiopathy—Conjugated Estrogens—prostate cancer	0.000589	0.00584	CcSEcCtD
Fospropofol—Vomiting—Flutamide—prostate cancer	0.000587	0.00582	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.000586	0.00581	CcSEcCtD
Fospropofol—Pruritus—Degarelix—prostate cancer	0.000586	0.00581	CcSEcCtD
Fospropofol—Mediastinal disorder—Conjugated Estrogens—prostate cancer	0.000585	0.0058	CcSEcCtD
Fospropofol—Headache—Nilutamide—prostate cancer	0.000581	0.00576	CcSEcCtD
Fospropofol—Headache—Flutamide—prostate cancer	0.000578	0.00574	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000578	0.00573	CcSEcCtD
Fospropofol—Pain—Bicalutamide—prostate cancer	0.000572	0.00568	CcSEcCtD
Fospropofol—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000555	0.0055	CcSEcCtD
Fospropofol—Stinging—Epirubicin—prostate cancer	0.000555	0.0055	CcSEcCtD
Fospropofol—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000554	0.00549	CcSEcCtD
Fospropofol—Nausea—Nilutamide—prostate cancer	0.000551	0.00546	CcSEcCtD
Fospropofol—Skin disorder—Ethinyl Estradiol—prostate cancer	0.000549	0.00545	CcSEcCtD
Fospropofol—Nausea—Flutamide—prostate cancer	0.000548	0.00544	CcSEcCtD
Fospropofol—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000546	0.00541	CcSEcCtD
Fospropofol—Propofol—CYP3A4—prostate cancer	0.000542	0.0696	CrCbGaD
Fospropofol—Hepatic failure—Docetaxel—prostate cancer	0.000538	0.00534	CcSEcCtD
Fospropofol—Vomiting—Degarelix—prostate cancer	0.000526	0.00522	CcSEcCtD
Fospropofol—Hepatic failure—Capecitabine—prostate cancer	0.000521	0.00517	CcSEcCtD
Fospropofol—Headache—Degarelix—prostate cancer	0.000519	0.00515	CcSEcCtD
Fospropofol—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000517	0.00513	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—prostate cancer	0.000513	0.00509	CcSEcCtD
Fospropofol—Cough—Goserelin—prostate cancer	0.000498	0.00494	CcSEcCtD
Fospropofol—Vomiting—Cabazitaxel—prostate cancer	0.000496	0.00492	CcSEcCtD
Fospropofol—Cough—Conjugated Estrogens—prostate cancer	0.000493	0.00489	CcSEcCtD
Fospropofol—Nausea—Degarelix—prostate cancer	0.000492	0.00488	CcSEcCtD
Fospropofol—Headache—Cabazitaxel—prostate cancer	0.000489	0.00485	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000488	0.00484	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000482	0.00478	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000478	0.00474	CcSEcCtD
Fospropofol—Pruritus—Bicalutamide—prostate cancer	0.000473	0.0047	CcSEcCtD
Fospropofol—Angiopathy—Estradiol—prostate cancer	0.000471	0.00468	CcSEcCtD
Fospropofol—Mediastinal disorder—Estradiol—prostate cancer	0.000468	0.00464	CcSEcCtD
Fospropofol—Nausea—Cabazitaxel—prostate cancer	0.000463	0.0046	CcSEcCtD
Fospropofol—Nervous system disorder—Goserelin—prostate cancer	0.000457	0.00453	CcSEcCtD
Fospropofol—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000452	0.00449	CcSEcCtD
Fospropofol—Skin disorder—Goserelin—prostate cancer	0.000452	0.00449	CcSEcCtD
Fospropofol—Ventricular tachycardia—Epirubicin—prostate cancer	0.000449	0.00446	CcSEcCtD
Fospropofol—Skin disorder—Conjugated Estrogens—prostate cancer	0.000448	0.00444	CcSEcCtD
Fospropofol—Hypotension—Goserelin—prostate cancer	0.000435	0.00432	CcSEcCtD
Fospropofol—Hypotension—Conjugated Estrogens—prostate cancer	0.000431	0.00427	CcSEcCtD
Fospropofol—Vomiting—Bicalutamide—prostate cancer	0.000425	0.00422	CcSEcCtD
Fospropofol—Headache—Bicalutamide—prostate cancer	0.000419	0.00416	CcSEcCtD
Fospropofol—Paraesthesia—Goserelin—prostate cancer	0.000418	0.00415	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—prostate cancer	0.000416	0.00413	CcSEcCtD
Fospropofol—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000414	0.00411	CcSEcCtD
Fospropofol—Pruritus—Ethinyl Estradiol—prostate cancer	0.0004	0.00397	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000398	0.00395	CcSEcCtD
Fospropofol—Pain—Goserelin—prostate cancer	0.000398	0.00395	CcSEcCtD
Fospropofol—Nausea—Bicalutamide—prostate cancer	0.000397	0.00394	CcSEcCtD
Fospropofol—Cough—Estradiol—prostate cancer	0.000395	0.00391	CcSEcCtD
Fospropofol—Pain—Conjugated Estrogens—prostate cancer	0.000394	0.00391	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000382	0.00379	CcSEcCtD
Fospropofol—Cough—Mitoxantrone—prostate cancer	0.000368	0.00365	CcSEcCtD
Fospropofol—Angiopathy—Etoposide—prostate cancer	0.000365	0.00362	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—prostate cancer	0.000363	0.0036	CcSEcCtD
Fospropofol—Mediastinal disorder—Etoposide—prostate cancer	0.000363	0.0036	CcSEcCtD
Fospropofol—Nervous system disorder—Estradiol—prostate cancer	0.000362	0.00359	CcSEcCtD
Fospropofol—Vomiting—Ethinyl Estradiol—prostate cancer	0.00036	0.00357	CcSEcCtD
Fospropofol—Skin disorder—Estradiol—prostate cancer	0.000358	0.00356	CcSEcCtD
Fospropofol—Headache—Ethinyl Estradiol—prostate cancer	0.000354	0.00352	CcSEcCtD
Fospropofol—Nausea—Ethinyl Estradiol—prostate cancer	0.000336	0.00333	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—prostate cancer	0.000336	0.00333	CcSEcCtD
Fospropofol—Skin disorder—Mitoxantrone—prostate cancer	0.000334	0.00331	CcSEcCtD
Fospropofol—Paraesthesia—Estradiol—prostate cancer	0.000331	0.00329	CcSEcCtD
Fospropofol—Pruritus—Goserelin—prostate cancer	0.000329	0.00327	CcSEcCtD
Fospropofol—Pruritus—Conjugated Estrogens—prostate cancer	0.000326	0.00324	CcSEcCtD
Fospropofol—Hypotension—Mitoxantrone—prostate cancer	0.000321	0.00319	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Estradiol—prostate cancer	0.000319	0.00316	CcSEcCtD
Fospropofol—Pain—Estradiol—prostate cancer	0.000316	0.00313	CcSEcCtD
Fospropofol—Paraesthesia—Mitoxantrone—prostate cancer	0.000309	0.00306	CcSEcCtD
Fospropofol—Cough—Etoposide—prostate cancer	0.000306	0.00303	CcSEcCtD
Fospropofol—Angiopathy—Docetaxel—prostate cancer	0.000304	0.00301	CcSEcCtD
Fospropofol—Mediastinal disorder—Docetaxel—prostate cancer	0.000302	0.00299	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000296	0.00294	CcSEcCtD
Fospropofol—Vomiting—Goserelin—prostate cancer	0.000296	0.00294	CcSEcCtD
Fospropofol—Pain—Mitoxantrone—prostate cancer	0.000294	0.00292	CcSEcCtD
Fospropofol—Angiopathy—Capecitabine—prostate cancer	0.000294	0.00292	CcSEcCtD
Fospropofol—Vomiting—Conjugated Estrogens—prostate cancer	0.000293	0.00291	CcSEcCtD
Fospropofol—Mediastinal disorder—Capecitabine—prostate cancer	0.000292	0.0029	CcSEcCtD
Fospropofol—Headache—Goserelin—prostate cancer	0.000292	0.00289	CcSEcCtD
Fospropofol—Headache—Conjugated Estrogens—prostate cancer	0.000289	0.00287	CcSEcCtD
Fospropofol—Skin disorder—Etoposide—prostate cancer	0.000278	0.00276	CcSEcCtD
Fospropofol—Nausea—Goserelin—prostate cancer	0.000277	0.00274	CcSEcCtD
Fospropofol—Nausea—Conjugated Estrogens—prostate cancer	0.000274	0.00272	CcSEcCtD
Fospropofol—Hypotension—Etoposide—prostate cancer	0.000267	0.00265	CcSEcCtD
Fospropofol—Angiopathy—Prednisone—prostate cancer	0.000262	0.0026	CcSEcCtD
Fospropofol—Pruritus—Estradiol—prostate cancer	0.000261	0.00259	CcSEcCtD
Fospropofol—Paraesthesia—Etoposide—prostate cancer	0.000257	0.00255	CcSEcCtD
Fospropofol—Cough—Docetaxel—prostate cancer	0.000254	0.00252	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Etoposide—prostate cancer	0.000247	0.00245	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000246	0.00244	CcSEcCtD
Fospropofol—Cough—Capecitabine—prostate cancer	0.000246	0.00244	CcSEcCtD
Fospropofol—Pain—Etoposide—prostate cancer	0.000245	0.00243	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000238	0.00237	CcSEcCtD
Fospropofol—Vomiting—Estradiol—prostate cancer	0.000235	0.00233	CcSEcCtD
Fospropofol—Nervous system disorder—Docetaxel—prostate cancer	0.000233	0.00231	CcSEcCtD
Fospropofol—Headache—Estradiol—prostate cancer	0.000231	0.00229	CcSEcCtD
Fospropofol—Skin disorder—Docetaxel—prostate cancer	0.000231	0.00229	CcSEcCtD
Fospropofol—Nervous system disorder—Capecitabine—prostate cancer	0.000226	0.00224	CcSEcCtD
Fospropofol—Skin disorder—Capecitabine—prostate cancer	0.000224	0.00222	CcSEcCtD
Fospropofol—Hypotension—Docetaxel—prostate cancer	0.000222	0.0022	CcSEcCtD
Fospropofol—Nausea—Estradiol—prostate cancer	0.000219	0.00217	CcSEcCtD
Fospropofol—Vomiting—Mitoxantrone—prostate cancer	0.000219	0.00217	CcSEcCtD
Fospropofol—Headache—Mitoxantrone—prostate cancer	0.000215	0.00214	CcSEcCtD
Fospropofol—Hypotension—Capecitabine—prostate cancer	0.000215	0.00213	CcSEcCtD
Fospropofol—Paraesthesia—Docetaxel—prostate cancer	0.000213	0.00212	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000212	0.00211	CcSEcCtD
Fospropofol—Paraesthesia—Capecitabine—prostate cancer	0.000207	0.00205	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000205	0.00204	CcSEcCtD
Fospropofol—Angiopathy—Epirubicin—prostate cancer	0.000205	0.00203	CcSEcCtD
Fospropofol—Nausea—Mitoxantrone—prostate cancer	0.000204	0.00203	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—prostate cancer	0.000203	0.00202	CcSEcCtD
Fospropofol—Pain—Docetaxel—prostate cancer	0.000203	0.00202	CcSEcCtD
Fospropofol—Pruritus—Etoposide—prostate cancer	0.000202	0.00201	CcSEcCtD
Fospropofol—Nervous system disorder—Prednisone—prostate cancer	0.000201	0.00199	CcSEcCtD
Fospropofol—Skin disorder—Prednisone—prostate cancer	0.000199	0.00198	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000199	0.00197	CcSEcCtD
Fospropofol—Pain—Capecitabine—prostate cancer	0.000197	0.00195	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—prostate cancer	0.000189	0.00188	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—prostate cancer	0.000188	0.00187	CcSEcCtD
Fospropofol—Paraesthesia—Prednisone—prostate cancer	0.000184	0.00183	CcSEcCtD
Fospropofol—Vomiting—Etoposide—prostate cancer	0.000182	0.0018	CcSEcCtD
Fospropofol—Headache—Etoposide—prostate cancer	0.000179	0.00178	CcSEcCtD
Fospropofol—Cough—Epirubicin—prostate cancer	0.000171	0.0017	CcSEcCtD
Fospropofol—Nausea—Etoposide—prostate cancer	0.00017	0.00169	CcSEcCtD
Fospropofol—Pruritus—Docetaxel—prostate cancer	0.000168	0.00167	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000166	0.00165	CcSEcCtD
Fospropofol—Pruritus—Capecitabine—prostate cancer	0.000163	0.00162	CcSEcCtD
Fospropofol—Cough—Doxorubicin—prostate cancer	0.000159	0.00157	CcSEcCtD
Fospropofol—Nervous system disorder—Epirubicin—prostate cancer	0.000157	0.00156	CcSEcCtD
Fospropofol—Skin disorder—Epirubicin—prostate cancer	0.000156	0.00155	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000154	0.00152	CcSEcCtD
Fospropofol—Vomiting—Docetaxel—prostate cancer	0.000151	0.0015	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—prostate cancer	0.00015	0.00149	CcSEcCtD
Fospropofol—Headache—Docetaxel—prostate cancer	0.000149	0.00148	CcSEcCtD
Fospropofol—Vomiting—Capecitabine—prostate cancer	0.000146	0.00145	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—prostate cancer	0.000145	0.00144	CcSEcCtD
Fospropofol—Pruritus—Prednisone—prostate cancer	0.000145	0.00144	CcSEcCtD
Fospropofol—Headache—Capecitabine—prostate cancer	0.000144	0.00143	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—prostate cancer	0.000144	0.00143	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—prostate cancer	0.000144	0.00143	CcSEcCtD
Fospropofol—Nausea—Docetaxel—prostate cancer	0.000141	0.0014	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—prostate cancer	0.000139	0.00138	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000138	0.00137	CcSEcCtD
Fospropofol—Pain—Epirubicin—prostate cancer	0.000137	0.00136	CcSEcCtD
Fospropofol—Nausea—Capecitabine—prostate cancer	0.000137	0.00136	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—prostate cancer	0.000133	0.00132	CcSEcCtD
Fospropofol—Vomiting—Prednisone—prostate cancer	0.00013	0.00129	CcSEcCtD
Fospropofol—Headache—Prednisone—prostate cancer	0.000128	0.00127	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000128	0.00127	CcSEcCtD
Fospropofol—Pain—Doxorubicin—prostate cancer	0.000127	0.00126	CcSEcCtD
Fospropofol—Nausea—Prednisone—prostate cancer	0.000122	0.00121	CcSEcCtD
Fospropofol—Pruritus—Epirubicin—prostate cancer	0.000113	0.00113	CcSEcCtD
Fospropofol—Pruritus—Doxorubicin—prostate cancer	0.000105	0.00104	CcSEcCtD
Fospropofol—Vomiting—Epirubicin—prostate cancer	0.000102	0.00101	CcSEcCtD
Fospropofol—Headache—Epirubicin—prostate cancer	0.0001	0.000996	CcSEcCtD
Fospropofol—Nausea—Epirubicin—prostate cancer	9.52e-05	0.000945	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—prostate cancer	9.43e-05	0.000936	CcSEcCtD
Fospropofol—Headache—Doxorubicin—prostate cancer	9.29e-05	0.000922	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—prostate cancer	8.81e-05	0.000874	CcSEcCtD
Fospropofol—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.58e-05	0.000274	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.57e-05	0.000273	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	2.57e-05	0.000273	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	2.57e-05	0.000273	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.57e-05	0.000273	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.54e-05	0.000269	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.52e-05	0.000268	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	2.52e-05	0.000267	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	2.5e-05	0.000265	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	2.49e-05	0.000264	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.48e-05	0.000263	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.47e-05	0.000263	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MDM2—prostate cancer	2.47e-05	0.000262	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	2.46e-05	0.000261	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.45e-05	0.00026	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CLU—prostate cancer	2.43e-05	0.000258	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.41e-05	0.000256	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—RXRA—prostate cancer	2.4e-05	0.000255	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.4e-05	0.000254	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MDM2—prostate cancer	2.4e-05	0.000254	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	2.38e-05	0.000253	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.38e-05	0.000252	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.36e-05	0.00025	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—RXRA—prostate cancer	2.35e-05	0.00025	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MDM2—prostate cancer	2.35e-05	0.00025	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—PPARA—prostate cancer	2.34e-05	0.000248	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—prostate cancer	2.33e-05	0.000247	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MDM2—prostate cancer	2.31e-05	0.000245	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	2.31e-05	0.000245	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.3e-05	0.000244	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MDM2—prostate cancer	2.3e-05	0.000244	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.29e-05	0.000243	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MDM2—prostate cancer	2.26e-05	0.000239	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GRB7—prostate cancer	2.22e-05	0.000236	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	2.22e-05	0.000235	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.21e-05	0.000235	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	2.2e-05	0.000234	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—PPARA—prostate cancer	2.18e-05	0.000231	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.18e-05	0.000231	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PSAT1—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CBR1—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADI1—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CSAD—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GRHL1—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TST—prostate cancer	2.17e-05	0.00023	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.16e-05	0.00023	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—PPARA—prostate cancer	2.15e-05	0.000228	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—prostate cancer	2.14e-05	0.000227	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.12e-05	0.000225	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—GNG5—prostate cancer	2.11e-05	0.000224	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.08e-05	0.000221	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.06e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—prostate cancer	2.05e-05	0.000218	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	2.04e-05	0.000216	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UGT2B15—prostate cancer	2.02e-05	0.000214	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UGT2B17—prostate cancer	2.02e-05	0.000214	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CKMT2—prostate cancer	2.02e-05	0.000214	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GRHPR—prostate cancer	2.02e-05	0.000214	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MDM2—prostate cancer	1.97e-05	0.000209	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.97e-05	0.000209	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.97e-05	0.000209	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.94e-05	0.000206	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.92e-05	0.000204	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	1.91e-05	0.000203	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PGAM2—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM3—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AOX1—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT2B1—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAGLU—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RFK—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MBTPS1—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—prostate cancer	1.88e-05	0.000199	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	1.88e-05	0.000199	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.85e-05	0.000197	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.85e-05	0.000197	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.84e-05	0.000196	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	1.83e-05	0.000194	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	1.83e-05	0.000194	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.83e-05	0.000194	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKACB—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism—DEGS1—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP3A43—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAT1—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SRD5A2—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AMACR—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.77e-05	0.000188	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.76e-05	0.000186	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—THBS1—prostate cancer	1.75e-05	0.000186	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.73e-05	0.000184	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	1.73e-05	0.000183	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD17B1—prostate cancer	1.71e-05	0.000182	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.71e-05	0.000182	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	1.71e-05	0.000181	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.71e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCZ—prostate cancer	1.7e-05	0.00018	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.65e-05	0.000175	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.65e-05	0.000175	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.64e-05	0.000174	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.62e-05	0.000172	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	1.58e-05	0.000168	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.57e-05	0.000167	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.56e-05	0.000166	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.56e-05	0.000165	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.55e-05	0.000164	CbGpPWpGaD
Fospropofol—ALB—Metabolism—B4GALT4—prostate cancer	1.53e-05	0.000162	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HPGD—prostate cancer	1.53e-05	0.000162	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	1.52e-05	0.000161	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.52e-05	0.000161	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	1.5e-05	0.000159	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—prostate cancer	1.49e-05	0.000158	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.49e-05	0.000158	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.47e-05	0.000156	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.46e-05	0.000155	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.45e-05	0.000154	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCQ—prostate cancer	1.44e-05	0.000153	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TNFRSF21—prostate cancer	1.44e-05	0.000152	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAUR—prostate cancer	1.43e-05	0.000151	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.4e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP7B1—prostate cancer	1.4e-05	0.000148	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTAP—prostate cancer	1.4e-05	0.000148	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	1.39e-05	0.000148	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.37e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT1E1—prostate cancer	1.36e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SRD5A1—prostate cancer	1.36e-05	0.000145	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VAV3—prostate cancer	1.32e-05	0.000141	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	1.32e-05	0.00014	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.32e-05	0.00014	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.3e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACSL4—prostate cancer	1.3e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD17B3—prostate cancer	1.3e-05	0.000138	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITPR1—prostate cancer	1.28e-05	0.000136	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.28e-05	0.000136	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.25e-05	0.000133	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ARG2—prostate cancer	1.24e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PHGDH—prostate cancer	1.24e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UMPS—prostate cancer	1.24e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.24e-05	0.000132	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.24e-05	0.000131	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LDHB—prostate cancer	1.22e-05	0.00013	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	1.22e-05	0.000129	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP3A5—prostate cancer	1.2e-05	0.000127	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	1.18e-05	0.000125	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PDHA1—prostate cancer	1.16e-05	0.000123	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTA3—prostate cancer	1.16e-05	0.000123	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UCP3—prostate cancer	1.16e-05	0.000123	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TCN2—prostate cancer	1.16e-05	0.000123	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGB3—prostate cancer	1.14e-05	0.000121	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC22A3—prostate cancer	1.1e-05	0.000117	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD3B1—prostate cancer	1.1e-05	0.000117	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.07e-05	0.000114	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	1.06e-05	0.000113	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTA4—prostate cancer	1.06e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TBXAS1—prostate cancer	1.06e-05	0.000112	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.03e-05	0.00011	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.03e-05	0.00011	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTA2—prostate cancer	1.03e-05	0.00011	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT1A1—prostate cancer	1.02e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCG5—prostate cancer	1.02e-05	0.000108	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—prostate cancer	1e-05	0.000106	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTA1—prostate cancer	9.95e-06	0.000106	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTO1—prostate cancer	9.84e-06	0.000104	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAT2—prostate cancer	9.84e-06	0.000104	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD3B2—prostate cancer	9.84e-06	0.000104	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CAV1—prostate cancer	9.77e-06	0.000104	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	9.48e-06	0.000101	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.46e-06	0.0001	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLCB2—prostate cancer	9.43e-06	0.0001	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2C18—prostate cancer	9.43e-06	0.0001	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LRP2—prostate cancer	9.43e-06	0.0001	CbGpPWpGaD
Fospropofol—ALB—Metabolism—P4HB—prostate cancer	9.25e-06	9.82e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC22A1—prostate cancer	9e-06	9.56e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	9e-06	9.55e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CG—prostate cancer	8.9e-06	9.45e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.9e-06	9.45e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—EGF—prostate cancer	8.8e-06	9.34e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SULT2A1—prostate cancer	8.77e-06	9.31e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MED12—prostate cancer	8.63e-06	9.16e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GNG5—prostate cancer	8.56e-06	9.09e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CREBBP—prostate cancer	8.25e-06	8.76e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOA3—prostate cancer	8.25e-06	8.76e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF1—prostate cancer	8.15e-06	8.65e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.1e-06	8.6e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	8.07e-06	8.56e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HPGDS—prostate cancer	7.87e-06	8.35e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CD—prostate cancer	7.83e-06	8.31e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2C19—prostate cancer	7.82e-06	8.3e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINE1—prostate cancer	7.74e-06	8.22e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—prostate cancer	7.63e-06	8.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ACHE—prostate cancer	7.63e-06	8.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2A6—prostate cancer	7.54e-06	8.01e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.51e-06	7.98e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS3—prostate cancer	7.39e-06	7.85e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKR1C3—prostate cancer	7.34e-06	7.79e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PRKACB—prostate cancer	7.3e-06	7.75e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP17A1—prostate cancer	7.22e-06	7.67e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—JAK2—prostate cancer	7.18e-06	7.62e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.14e-06	7.59e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.12e-06	7.56e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOA2—prostate cancer	6.88e-06	7.31e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CB—prostate cancer	6.82e-06	7.24e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.59e-06	7e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC5A5—prostate cancer	6.57e-06	6.97e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2E1—prostate cancer	6.41e-06	6.81e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NQO1—prostate cancer	6.34e-06	6.73e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—prostate cancer	6.26e-06	6.65e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TH—prostate cancer	6.25e-06	6.64e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.21e-06	6.59e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP3A4—prostate cancer	6.18e-06	6.57e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.15e-06	6.53e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1B1—prostate cancer	6.08e-06	6.45e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GGT1—prostate cancer	5.89e-06	6.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOA1—prostate cancer	5.8e-06	6.16e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP19A1—prostate cancer	5.72e-06	6.07e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—EP300—prostate cancer	5.62e-06	5.97e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RXRA—prostate cancer	5.52e-06	5.86e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—prostate cancer	5.47e-06	5.8e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.37e-06	5.7e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—prostate cancer	5.32e-06	5.65e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—COMT—prostate cancer	5.31e-06	5.64e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—prostate cancer	5.29e-06	5.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ITPR1—prostate cancer	5.2e-06	5.53e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.12e-06	5.43e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMS—prostate cancer	4.92e-06	5.22e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—prostate cancer	4.89e-06	5.19e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—prostate cancer	4.86e-06	5.16e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—LPL—prostate cancer	4.77e-06	5.07e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1A1—prostate cancer	4.61e-06	4.89e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ERCC2—prostate cancer	4.57e-06	4.85e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—prostate cancer	4.53e-06	4.8e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—prostate cancer	4.3e-06	4.56e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARA—prostate cancer	4.21e-06	4.47e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PIK3CA—prostate cancer	4.16e-06	4.41e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—prostate cancer	4.02e-06	4.27e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CAV1—prostate cancer	3.96e-06	4.21e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.79e-06	4.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CG—prostate cancer	3.61e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—INS—prostate cancer	3.42e-06	3.63e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—prostate cancer	3.4e-06	3.61e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CREBBP—prostate cancer	3.35e-06	3.55e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CD—prostate cancer	3.17e-06	3.37e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NOS3—prostate cancer	3e-06	3.18e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CB—prostate cancer	2.77e-06	2.94e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—prostate cancer	2.74e-06	2.91e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—prostate cancer	2.39e-06	2.54e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—EP300—prostate cancer	2.28e-06	2.42e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PIK3CA—prostate cancer	1.69e-06	1.79e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—prostate cancer	1.38e-06	1.46e-05	CbGpPWpGaD
